10 Amgen executives
With Amgen's CFO, Peter Griffith, and Chief Accounting Officer Matthew Busch on finance, the rest of this Amgen executive group covers operations and global manufacturing, research and R&D, commercial operations, technology and AI, international general management and the former Chief Transformation Officer. Nine hold current Amgen roles, which suits a biotech, investor or supplier asking how research spending, manufacturing capacity and launches are weighed.
Professionals to explore
Arleen Paulino
LinkedInExperience: Senior Vice President Global Manufacturing · Amgen
Arleen Paulino has been Senior Vice President Global Manufacturing at Amgen since 2018, responsible for global manufacturing operations and reliable supply of products to patients. Earlier Amgen titles are Vice President Singapore Site Operations (2016–2018), Vice President Clinical Operations & Supply Chain (2015), Executive Director Clinical Operations and Supply Chain (2012–2015) and Executive Director Global Process Engineering, PD (2005–2012). A fit for questions on moving products from clinical supply to commercial manufacturing.
Is this you? Claim your profile and get paid for calls.
Brian McNamee
LinkedInExperience: Former Executive Vice President, Chief Transformation Officer · Amgen
Brian McNamee was Executive Vice President, Chief Transformation Officer at Amgen from 2013 to 2019, responsible for leading Amgen's Full Potential transformation, after Chief Human Resource Officer there (2001–2013). Earlier titles include Vice President Human Resources at Dell Technologies (2000–2001), Senior Vice President Human Resources at National Broadcasting Company (1997–1999) and Human Resource Executive at GE (1988–1997). A fit for questions on company-wide transformation programs.
Is this you? Claim your profile and get paid for calls.
David Reese
LinkedInExperience: Former Executive Vice President, Research and Development · Amgen
Physician-scientist David Reese was Executive Vice President, Research and Development at Amgen (2018–2023) and Chief Technology Officer (2023–2026), and has held Executive Vice President since 2026. Earlier Amgen titles are Senior Vice President, Translational Sciences and Oncology (2015–2018) and Vice President, Translational Sciences (2014–2015). A fit for questions on R&D portfolio decisions and on applying technology to drug development.
Is this you? Claim your profile and get paid for calls.
Esteban Santos
LinkedInExperience: Executive Vice President, Operations · Amgen
Esteban Santos is responsible for the Operations organization at Amgen, covering Manufacturing, Process Development, Quality, Engineering and Global Supply Chain, as Executive Vice President, Operations since 2016. Earlier Amgen titles are Senior VP, Manufacturing Operations (2013–2016), Vice president, Drug Product Operations (2012–2013), VP Site Operations (2011–2012) and Vice President of Global Engineering (2008–2011). A fit for questions on manufacturing, quality and supply chain.
Is this you? Claim your profile and get paid for calls.
Gilles Marrache
LinkedInExperience: Senior Vice President General Manager Europe, Latin-America, Middle-East Africa, Canada · Amgen
Gilles Marrache, based in Zug, has been Senior Vice President General Manager Europe, Latin-America, Middle-East Africa, Canada at Amgen since 2021. Earlier Amgen titles are Senior Vice President General Manager Europe Region (2018–2021), Senior Vice President General Manager Intercontinental Region (2015–2018), Vice President, Global Marketing Cardiovascular, Metabolic and Neurosciences Therapeutic Area (2013–2015) and Vice President International Marketing & Business Operations (2010–2012). A fit for questions on commercial leadership across Europe, Latin America, the Middle East, Africa and Canada.
Is this you? Claim your profile and get paid for calls.
Howard Chang
LinkedInExperience: SVP Global Research & Chief Scientific Officer · Amgen
Howard Chang, based in Stanford, California, has been SVP Global Research & Chief Scientific Officer at Amgen since 2024, leading all aspects of discovery research and overseeing operations in key research hubs. Co-founder roles are at Orbital Therapeutics (since 2022), Cartography Biosciences (since 2020), Boundless Bio (since 2019) and Accent Therapeutics, Inc. (since 2017). A fit for questions on discovery research strategy and on co-founding new companies.
Is this you? Claim your profile and get paid for calls.
Matthew Busch
LinkedInExperience: Chief Accounting Officer (CAO) · Amgen
Matthew Busch's Amgen finance titles run from Director, Technical Accounting and External Reporting (2015–2017), Executive Director, Corporate Accounting (2017–2020), Executive Director, Corporate Finance (2020–2021) and Vice President Corporate Finance (2021–2023) to Chief Accounting Officer (CAO) since 2023. A fit for questions on technical accounting and external reporting at a biotech.
Is this you? Claim your profile and get paid for calls.
Murdo Gordon
LinkedInExperience: Executive Vice President Global Commercial Operations · Amgen
Murdo Gordon has held Executive Vice President Global Commercial Operations at Amgen since 2018, a title their LinkedIn profile gives as Executive Vice President, Global Markets and Policy. Bristol Myers Squibb roles are Chief Commercial Officer (2016–2018), Head of Worldwide Markets (2015–2016) and President, US (2013–2015), and Murdo Gordon was also Director at Robert Wood Johnson University Hospital (2012–2018). A fit for questions on commercial strategy across global markets.
Is this you? Claim your profile and get paid for calls.
Peter Griffith
LinkedInExperience: Executive Vice President, Finance and CFO · Amgen
Peter Griffith has been Executive Vice President, Finance and CFO at Amgen since 2019, after President of Sherwood Canyon Group, LLC (2019). EY roles are Global Vice Chair - Corporate Development (2014–2019), Global Managing Partner, Operations and Finance (2010–2014) and Vice Chair, Pacific Southwest Area (2006–2010). The CFO seat and the corporate development role make Peter a fit for questions on capital allocation and deals.
Is this you? Claim your profile and get paid for calls.
Sean Bruich
LinkedInExperience: Chief Technology Officer · Amgen
Sean Bruich became Chief Technology Officer at Amgen in 2026, leading enterprise technology across AI/ML strategy and engineering and data strategy, after SVP, Artificial Intelligence (AI) & Data there (2024–2026). Nike roles are Global Vice President, Insights, Data Science, & Analytics (2024), VP Global Consumer Science & Insights (2020–2024) and VP Global Membership & Consumer Knowledge (user growth & loyalty) (2018–2020). A fit for questions on enterprise AI and data programs.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Capital allocation and reporting questions go to Peter Griffith or Matthew Busch. Esteban Santos and Arleen Paulino cover operations and manufacturing supply, Howard Chang and David Reese research and development, Murdo Gordon and Gilles Marrache commercial markets, Sean Bruich AI and data, and Brian McNamee (former) company-wide transformation and human resources.
Questions to take into the conversation
- 01How does a biotech's finance team weigh internal research programs against acquisitions when setting the annual budget?
- 02What changes in manufacturing and supply planning when a medicine moves from clinical supply to commercial launch?
- 03How does a biotech roll out AI and data tools across discovery research without each research hub building its own?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.